-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the evening of February 16, Puli Pharmaceuticals recently received the marketing authorization of vancomycin hydrochloride 500mg for injection issued by the Ministry of Health of Costa Rica
Vancomycin hydrochloride is used to treat serious infections caused by susceptible strains of methicillin-resistant (beta-lactam) staphylococci
In addition, vancomycin was first isolated from soil and developed by Eli Lilly, which was approved by the FDA in 1958